LyGenesis

Pittsburgh, United States

LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.

$19.0M raised

Oct 2023

Series A

Top Investors

JuvenescenceLongevity Vision FundPrime Movers Lab

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has LyGenesis raised?

LyGenesis has raised $19.0M in total funding. The most recent round was Series A. The last funding was announced in October 2023.

Who are LyGenesis's investors?

LyGenesis's investors include Juvenescence, Longevity Vision Fund, Prime Movers Lab.

Where is LyGenesis headquartered?

LyGenesis is headquartered in Pittsburgh, United States.

What does LyGenesis do?

LyGenesis is an organ regeneration company that facilitates organ regeneration and transplant.

What stage is LyGenesis at?

LyGenesis is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 24, 2023.

MLA

"LyGenesis — Funding & Investors." VCBacked, October 24, 2023, https://www.vcbacked.co/company/lygenesis. Accessed June 17, 2026.

APA

VCBacked. (2023). LyGenesis — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/lygenesis

Wikipedia (cite web)

{{cite web |title=LyGenesis — Funding & Investors |url=https://www.vcbacked.co/company/lygenesis |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 24, 2023.